1. Skip to content

Mesothelioma Cancer Resources Blog

  • Mesothelioma Patients Sought for Clinical Trial

    Researchers are seeking 40 patients that have confirmed malignant mesothelioma, who are not candidates for surgery or radiation, to test the drug gefitinib. Gefitinib inhibits cellular growth in cancerous cells by targeting the proteins. The trade name for gefitinib is Iressa. Malignant mesothelioma is a cancer caused by exposure to airborne asbestos fibers. The fibers …

    Label: Clinical Trial Mesothelioma Treatments

    Posted on Monday, Sep 14, 2009